Selected References:

• American College of Obstetricians and Gynecologists (ACOG). 2019. ACOG Committee Opinion, number 782. Prevention of Group B Streptococcal early-onset disease in newborns: 2019. Obstet Gynecol, 134(1):e19-e40.
• Bae GE, et al. 2016. Acute placental villitis as evidence of fetal sepsis: an autopsy case report. Pediatr Dev Pathol 19(2): 165-168.
• Cape A, et al. 2013. Peripartum bacteremia in the era of group B streptococcus prophylaxis. Obstet Gynecol. 121(4):812-818.
• Charles D, Larsen B. 10986. Streptococcal puerperal sepsis and obstetric infections: a historical perspective. Rev Infect Dise 8:411-422.
• Daskalakis G, et al. 2023. Maternal Infection and Preterm Birth: From Molecular Basis to Clinical Implications. Children (Basel). 10(5):907.
• Giakoumelou S, et al. 2016. The role of infection in miscarriage. Hum Reprod Update. 22(1):116-33.
• Kenchington AL, Lamont RF. 2017. Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease. Expert Rev Vaccines. 16(1):15-25.
• Nan C, et al. 2015. Maternal group B streptococcus-related stillbirth: a systemic review. BJOG 122(11): 1437-1445.
• Oghbaei H, et al. 2020. Effects of bacteria on male fertility: spermatogenesis and sperm function. Life Sciences 256: 117891.
• Olver WJ, et al. 200. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed 83:F48-49.
• Polcwiartek LB, et al. 2021. Early-onset sepsis in term infants admitted to neonatal intensive care units (2011-2016). J Perinatol. 1(1):157-163.
• Petersen KB, et al. 2014. Increasing prevalence of group B streptococcal infection among pregnant women. Dan Med J. 2014 Sep;61(9):A4908.
• Ravel J, et al. 2021. Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am J Obstet Gyn 224(3): 251-257.
• Staford IA, et al. 2018. The strong correlation between neonatal early onset group B streptococcal disease and necrotizing enterocolitis. Eur J Obstet Gynecol Reprod Biol 223:93-97.
• S. Centers for Disease Control and Prevention (CDC). 2024. Clinical Overview of Group B Strep Disease. Available at: https://www.cdc.gov/group-b-strep/hcp/clinical-overview/index.html. Accessed September 30 2024.
• Verani JR, et al; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). 2010. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 59(RR-10):1-36.

Selected References:

• Ito S, et al. 1993. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol. 168:1393-9. Messinis IE, et al. 1985. Histamine H1 receptor participation in the control of prolactin secretion in postpartum. J Endocrinol Invest. 8:143-6.
• Pontiroli AE, et al. 1981. The effect of histamine and H1 and H2 receptors on prolactin and luteinizing hormone release in humans: sex differences and the role of stress. J Clin Endocrinol Metab. 52:924-8.
• Product information. Azelastine Nasal. Perrigo New York, 2024. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82610437-25f4-4ae0-9d6a-381e9932f87d.
• Suzuki Y, et al. 1981. Teratology and reproduction studies of azelastine, a novel antiallergic agent, in rats and rabbits. Arzneim-Forsch. 31:1225-30.
• Tatsumi K, et al. 1980. Studies of metabolic fate of a new antiallergic agent, azelastine. Jpn J Pharmacol. 30:37-48.

Selected References:

• ACAM2000® Product Insert. Revised 08/2024. Available at URL: https://www.fda.gov/media/75792/download.
• Centers for Disease Control and Prevention. 2016. Contraindications to vaccination: nonemergency use of smallpox vaccine. Available at URL: https://www.cdc.gov/smallpox/clinicians/vaccination-contraindications1.html.
• Meaney-Delman, DM, et al. 2022. A primer on monkeypox virus for obstetrician–gynecologists, Obstetrics & Gynecology. Published online July 11, 2022. DOI: https://doi.org/10.1097/AOG.0000000000004909.
• Ryan MD, et al. 2003. Women with smallpox vaccine exposure during pregnancy reported to the national smallpox vaccine in pregnancy registry — United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52(17):386-388.

Selected References:

• Repatha® Prescribing Information. Available online at https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Repatha/repatha_pi_hcp_english.pdf accessed on October 17, 2024.

Selected References:

• Bayliss H, et al. 2002. Anti-hypertensive drugs in pregnancy and fetal growth: evidence for «pharmacological programming» in the first trimester? Hypertens Pregnancy; 21:161-74.
• Bratton S, et al. 2024. Does atenolol use during pregnancy cause small for gestational age neonates? A meta-analysis. Journal of Perinatal Medicine, 52(8), 858-862.
• Caton AR, et al. 2009. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension; 54(1):63-70.
• Easterling TR, et al. 1999. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol; 93(5 Pt 1):725-733.
• Eyal S, et al. 2010. Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum. J Clin Pharmacol; 50:1301-9.
• Fogari R, et al. 1998. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. American journal of hypertension. 11(10): 1244-47.
• Fogari R, et al. 2002. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol; 58: 177–80.
• Guo D, et al. 2017. Hypertension and male fertility. The world journal of men’s health; 35.2: 59-64.
• Kirch W & Görg KG. 1982. Clinical pharmacokinetics of atenolol–a Circ J. 80(10): 2221-6.
• Lip GY, et al. 1997. Effect of atenolol on birth weight. Am J Cardiol; 79: 1436-8.
• Lwin EMP, et al. 2018. Estimation of atenolol transfer into milk and infant exposure during its use in lactating women. J Hum Lact; 34(3):592-599.
• Lydakis C, et al. 1999. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens; 12:541-7.
• Mayo Foundation for Medical Education and Research, 2022, Atenolol (Oral Route), Mayo 1: 1-10
• Montan S, et al. 1987. Fetal and uteroplacental haemodynamics during short term atenolol treatment of hypertension in pregnancy. Br J Obstet Gynaecol; 94:312-317.
• Orbach H, et al. 2013. Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol; 208(4): 301.e1-301.e6.
• Räsänen J, Jouppila P. 1995. Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study. Eur J Obstet Gynecol Reprod Biol; 62:195-201.
• Reynolds B, et al. 1984. First year of life after the use of atenolol in pregnancy associated with hypertension. Arch Dis Child; 59(11):1061-1063.
• Rubin PC, et al. 1983. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet; 1:431-4.
• Rubin PC, et al. 1984. Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. Am J Obstet Gynecol; 150:389-92.
• Schimmel M, et al. 1989. Toxic effect of atenolol consumed during breast feeding. J Pediatrics; 114:476-8.
• Tabacova S, et al. 2003. Atenolol developmental toxicity: animal-to-human comparisons. Birth Defects Res; 67:181-92.
• Tanaka K, 2016. Beta-blockers and fetal growth restriction in pregnant women with cardiovascular
• Thorley KJ, McAnish J. 1983. Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy. Biopharm Drug Dispos; 4:229-301.
• White WB, et al. 1984. Atenolol in human plasma and breast milk. Obstet Gynecol; 63 (S1):42-44. European journal of drug metabolism and pharmacokinetics, 7 (2), 81–91. https://doi.org/10.1007/BF03188723.